Zobrazeno 1 - 9
of 9
pro vyhledávání: '"K. G. Lobanova"'
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 84-95 (2022)
Insulin resistance (IR) is an important problem of humanity, which leads to development of many metabolic disorders. Сurrently the pathogenic mechanism of the development of IR is not completely investigated. Nevertheless, there are some hypotheses
Externí odkaz:
https://doaj.org/article/74cf40154c9f49f086e215f43ef20b54
Publikováno v:
Медицинский вестник Юга России, Vol 13, Iss 1, Pp 24-42 (2022)
It has now been established that the intestinal microbiota (CM) is one of the 11 links in the pathogenesis of type 2 diabetes mellitus (DM2). Th e fact is that when the composition of BM is disrupted and the concentration of its active metabolites ch
Externí odkaz:
https://doaj.org/article/9b9f72eed03b4d0e92a19242bab6ba46
Publikováno v:
Сахарный диабет, Vol 24, Iss 3, Pp 231-242 (2021)
BACKGROUND. Type 2 diabetes mellitus (T2DM) is an independent risk factor for adverse clinical outcomes in patients with Covid-19. There is currently insufficient data evaluating the efficacy and safety of drugs for the treatment of COVID-19, especia
Externí odkaz:
https://doaj.org/article/29d10e5a50dc4997bfee9c462bc4d108
Publikováno v:
Медицинский совет, Vol 0, Iss 7, Pp 184-191 (2021)
Introduction. According to various authors, uncompensated gestational diabetes mellitus (GDM) is accompanied by the development of many complications affecting the mother and fetus. However, published data on the prevalence of GDM and its complicatio
Externí odkaz:
https://doaj.org/article/611d6c80b100431d8ac5fb1031e2181c
Publikováno v:
Терапевтический архив, Vol 92, Iss 10, Pp 97-104 (2020)
Gut microbiota (GM) is a set of bacteria which colonize the gastrointestinal tract. GM and its active metabolites take part in intestinal and hepatic gluconeogenesis, in the synthesis of incretin hormones, and affect the regulation of appetite. Thus,
Externí odkaz:
https://doaj.org/article/bf7ed0a0a56d4f95ad70587356159842
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 20, Iss 1 (2021)
Aim. To assess the relationship between type 2 diabetes (T2D) and the course and outcomes of coronavirus disease 2019 (COVID-19), depending on clinical and laboratory parameters and comorbidities.Material and methods. A retrospective analysis of clin
Externí odkaz:
https://doaj.org/article/2fcc6a10ed04401fbcb21bc3b2740d57
Publikováno v:
Терапевтический архив, Vol 91, Iss 10, Pp 124-134 (2019)
Achievement of stabilization of carbohydrate metabolism in patients with diabetes mellitus, receiving renal replacement therapy with hemodialysis, is a significant problem in endocrinology. It has to do with multiple factors of this cohort of patient
Externí odkaz:
https://doaj.org/article/9acd8ab4864643c29d62ba8b76c8b481
Publikováno v:
European Heart Journal. 42
Introduction Cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM) are independent risk factors for the severe course of COVID-19. Thus, all patients with COVID-19, T2DM and CVD should be constant medical control and receive adequate thera
Autor:
Anastasia Sergeevna Severina, S A Martinov, Marina Vladimirovna Shestakova, K G Lobanova, M Sh Shamkhalova
Publikováno v:
Терапевтический архив, Vol 91, Iss 10, Pp 124-134 (2019)
Achievement of stabilization of carbohydrate metabolism in patients with diabetes mellitus, receiving renal replacement therapy with hemodialysis, is a significant problem in endocrinology. It has to do with multiple factors of this cohort of patient